That's the case with specialty biotech stock Vertex Pharmaceuticals (NASDAQ: VRTX). For example, Vertex has developed multiple generations of approved treatments for cystic fibrosis (CF), a genetic disease characterized by thick mucus production that can obstruct the lungs and pancreas. The Fed's dovish monetary policy, its ongoing quantitative easing, and even the future prospects of inflation are all reasons gold can maintain or advance from its current levels.